Share Prices & Company Research

Market News

08 Feb 2021 | 07:54

Dechra secures last international rights to Tri-Solfen

(Sharecast News) - Dechra Pharmaceuticals announced on Monday that it has secured the rights to market Tri-Solfen in Australia and New Zealand. and has acquired a further 1.5% of Medical Ethics for AUD 32.5m (£18.1m). The FTSE 250 firm said that now provided it with the rights to sell the veterinary pain management product Tri-Solfen in all international markets.

Under the agreement, Dechra said it will acquire the marketing authorisations and enter a long-term licensing agreement with Animal Ethics.

The agreement would provide Dechra with exclusive rights to sell and market Tri-Solfen, which is already registered for sheep and cattle and is sold in Australia and New Zealand with current annual sales of AUD 9.1m.

Under the terms of the deal, Dechra agreed to make an upfront payment of AUD 5m on signing, with the balance on the first commercial sale by Dechra into the Australian market, expected in July.

A royalty would also be paid on all net sales.

In addition to cattle and sheep, the product was being developed for other species, with the application for pigs being a primary focus, especially in the EU.

Following the acquisition from the current shareholders of the additional 1.5% of the issued share capital of Medical Ethics, the parent company of Animal Ethics, Dechra said it would hold 49.5% of the issued share capital of Medical Ethics.

"We are delighted to secure this agreement which now completes Dechra's worldwide rights to sell and market this multi-species pain management product," said chief executive officer Ian Page.

"Tri-Solfen significantly strengthens our FAP portfolio in Australia and New Zealand, will further our geographical expansion strategy and will enhance Dechra's reputation of providing clinically necessary, high quality, ethical veterinary pharmaceuticals."

At 0955 GMT, shares in Dechra Pharmaceuticals were up 2.43% at 3,714p.
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 14th May 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.